Request for Covid-19 Impact Assessment of this Report
The United States Biopharma Buffer market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Biopharma Buffer market, reaching US$ million by the year 2028. As for the Europe Biopharma Buffer landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Biopharma Buffer players cover Avantor, Alfa Aesar (Thermo Fisher), Merck, and Lonza, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Biopharma Buffer market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Phosphates Type
Acetates Type
TRIS Type
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Research Institution
Pharmaceutical Industry
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Avantor
Alfa Aesar (Thermo Fisher)
Merck
Lonza
Bio-Rad
BD
GE Healthcare
Promega Corporation
Hamilton Company
XZL BIO-TECHNOLOGY
SRL
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biopharma Buffer Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Biopharma Buffer by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Biopharma Buffer by Country/Region, 2017, 2022 & 2028
2.2 Biopharma Buffer Segment by Type
2.2.1 Phosphates Type
2.2.2 Acetates Type
2.2.3 TRIS Type
2.2.4 Others
2.3 Biopharma Buffer Sales by Type
2.3.1 Global Biopharma Buffer Sales Market Share by Type (2017-2022)
2.3.2 Global Biopharma Buffer Revenue and Market Share by Type (2017-2022)
2.3.3 Global Biopharma Buffer Sale Price by Type (2017-2022)
2.4 Biopharma Buffer Segment by Application
2.4.1 Research Institution
2.4.2 Pharmaceutical Industry
2.4.3 Others
2.5 Biopharma Buffer Sales by Application
2.5.1 Global Biopharma Buffer Sale Market Share by Application (2017-2022)
2.5.2 Global Biopharma Buffer Revenue and Market Share by Application (2017-2022)
2.5.3 Global Biopharma Buffer Sale Price by Application (2017-2022)
3 Global Biopharma Buffer by Company
3.1 Global Biopharma Buffer Breakdown Data by Company
3.1.1 Global Biopharma Buffer Annual Sales by Company (2020-2022)
3.1.2 Global Biopharma Buffer Sales Market Share by Company (2020-2022)
3.2 Global Biopharma Buffer Annual Revenue by Company (2020-2022)
3.2.1 Global Biopharma Buffer Revenue by Company (2020-2022)
3.2.2 Global Biopharma Buffer Revenue Market Share by Company (2020-2022)
3.3 Global Biopharma Buffer Sale Price by Company
3.4 Key Manufacturers Biopharma Buffer Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biopharma Buffer Product Location Distribution
3.4.2 Players Biopharma Buffer Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Biopharma Buffer by Geographic Region
4.1 World Historic Biopharma Buffer Market Size by Geographic Region (2017-2022)
4.1.1 Global Biopharma Buffer Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Biopharma Buffer Annual Revenue by Geographic Region
4.2 World Historic Biopharma Buffer Market Size by Country/Region (2017-2022)
4.2.1 Global Biopharma Buffer Annual Sales by Country/Region (2017-2022)
4.2.2 Global Biopharma Buffer Annual Revenue by Country/Region
4.3 Americas Biopharma Buffer Sales Growth
4.4 APAC Biopharma Buffer Sales Growth
4.5 Europe Biopharma Buffer Sales Growth
4.6 Middle East & Africa Biopharma Buffer Sales Growth
5 Americas
5.1 Americas Biopharma Buffer Sales by Country
5.1.1 Americas Biopharma Buffer Sales by Country (2017-2022)
5.1.2 Americas Biopharma Buffer Revenue by Country (2017-2022)
5.2 Americas Biopharma Buffer Sales by Type
5.3 Americas Biopharma Buffer Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biopharma Buffer Sales by Region
6.1.1 APAC Biopharma Buffer Sales by Region (2017-2022)
6.1.2 APAC Biopharma Buffer Revenue by Region (2017-2022)
6.2 APAC Biopharma Buffer Sales by Type
6.3 APAC Biopharma Buffer Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Biopharma Buffer by Country
7.1.1 Europe Biopharma Buffer Sales by Country (2017-2022)
7.1.2 Europe Biopharma Buffer Revenue by Country (2017-2022)
7.2 Europe Biopharma Buffer Sales by Type
7.3 Europe Biopharma Buffer Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Biopharma Buffer by Country
8.1.1 Middle East & Africa Biopharma Buffer Sales by Country (2017-2022)
8.1.2 Middle East & Africa Biopharma Buffer Revenue by Country (2017-2022)
8.2 Middle East & Africa Biopharma Buffer Sales by Type
8.3 Middle East & Africa Biopharma Buffer Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biopharma Buffer
10.3 Manufacturing Process Analysis of Biopharma Buffer
10.4 Industry Chain Structure of Biopharma Buffer
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Biopharma Buffer Distributors
11.3 Biopharma Buffer Customer
12 World Forecast Review for Biopharma Buffer by Geographic Region
12.1 Global Biopharma Buffer Market Size Forecast by Region
12.1.1 Global Biopharma Buffer Forecast by Region (2023-2028)
12.1.2 Global Biopharma Buffer Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Biopharma Buffer Forecast by Type
12.7 Global Biopharma Buffer Forecast by Application
13 Key Players Analysis
13.1 Avantor
13.1.1 Avantor Company Information
13.1.2 Avantor Biopharma Buffer Product Offered
13.1.3 Avantor Biopharma Buffer Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Avantor Main Business Overview
13.1.5 Avantor Latest Developments
13.2 Alfa Aesar (Thermo Fisher)
13.2.1 Alfa Aesar (Thermo Fisher) Company Information
13.2.2 Alfa Aesar (Thermo Fisher) Biopharma Buffer Product Offered
13.2.3 Alfa Aesar (Thermo Fisher) Biopharma Buffer Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Alfa Aesar (Thermo Fisher) Main Business Overview
13.2.5 Alfa Aesar (Thermo Fisher) Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Biopharma Buffer Product Offered
13.3.3 Merck Biopharma Buffer Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Lonza
13.4.1 Lonza Company Information
13.4.2 Lonza Biopharma Buffer Product Offered
13.4.3 Lonza Biopharma Buffer Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Lonza Main Business Overview
13.4.5 Lonza Latest Developments
13.5 Bio-Rad
13.5.1 Bio-Rad Company Information
13.5.2 Bio-Rad Biopharma Buffer Product Offered
13.5.3 Bio-Rad Biopharma Buffer Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Bio-Rad Main Business Overview
13.5.5 Bio-Rad Latest Developments
13.6 BD
13.6.1 BD Company Information
13.6.2 BD Biopharma Buffer Product Offered
13.6.3 BD Biopharma Buffer Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 BD Main Business Overview
13.6.5 BD Latest Developments
13.7 GE Healthcare
13.7.1 GE Healthcare Company Information
13.7.2 GE Healthcare Biopharma Buffer Product Offered
13.7.3 GE Healthcare Biopharma Buffer Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 GE Healthcare Main Business Overview
13.7.5 GE Healthcare Latest Developments
13.8 Promega Corporation
13.8.1 Promega Corporation Company Information
13.8.2 Promega Corporation Biopharma Buffer Product Offered
13.8.3 Promega Corporation Biopharma Buffer Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Promega Corporation Main Business Overview
13.8.5 Promega Corporation Latest Developments
13.9 Hamilton Company
13.9.1 Hamilton Company Company Information
13.9.2 Hamilton Company Biopharma Buffer Product Offered
13.9.3 Hamilton Company Biopharma Buffer Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Hamilton Company Main Business Overview
13.9.5 Hamilton Company Latest Developments
13.10 XZL BIO-TECHNOLOGY
13.10.1 XZL BIO-TECHNOLOGY Company Information
13.10.2 XZL BIO-TECHNOLOGY Biopharma Buffer Product Offered
13.10.3 XZL BIO-TECHNOLOGY Biopharma Buffer Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 XZL BIO-TECHNOLOGY Main Business Overview
13.10.5 XZL BIO-TECHNOLOGY Latest Developments
13.11 SRL
13.11.1 SRL Company Information
13.11.2 SRL Biopharma Buffer Product Offered
13.11.3 SRL Biopharma Buffer Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 SRL Main Business Overview
13.11.5 SRL Latest Developments
14 Research Findings and Conclusion
Table 1. Biopharma Buffer Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Biopharma Buffer Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Phosphates Type
Table 4. Major Players of Acetates Type
Table 5. Major Players of TRIS Type
Table 6. Major Players of Others
Table 7. Global Biopharma Buffer Sales by Type (2017-2022) & (KL)
Table 8. Global Biopharma Buffer Sales Market Share by Type (2017-2022)
Table 9. Global Biopharma Buffer Revenue by Type (2017-2022) & ($ million)
Table 10. Global Biopharma Buffer Revenue Market Share by Type (2017-2022)
Table 11. Global Biopharma Buffer Sale Price by Type (2017-2022) & (US$/L)
Table 12. Global Biopharma Buffer Sales by Application (2017-2022) & (KL)
Table 13. Global Biopharma Buffer Sales Market Share by Application (2017-2022)
Table 14. Global Biopharma Buffer Revenue by Application (2017-2022)
Table 15. Global Biopharma Buffer Revenue Market Share by Application (2017-2022)
Table 16. Global Biopharma Buffer Sale Price by Application (2017-2022) & (US$/L)
Table 17. Global Biopharma Buffer Sales by Company (2020-2022) & (KL)
Table 18. Global Biopharma Buffer Sales Market Share by Company (2020-2022)
Table 19. Global Biopharma Buffer Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Biopharma Buffer Revenue Market Share by Company (2020-2022)
Table 21. Global Biopharma Buffer Sale Price by Company (2020-2022) & (US$/L)
Table 22. Key Manufacturers Biopharma Buffer Producing Area Distribution and Sales Area
Table 23. Players Biopharma Buffer Products Offered
Table 24. Biopharma Buffer Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Biopharma Buffer Sales by Geographic Region (2017-2022) & (KL)
Table 28. Global Biopharma Buffer Sales Market Share Geographic Region (2017-2022)
Table 29. Global Biopharma Buffer Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Biopharma Buffer Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Biopharma Buffer Sales by Country/Region (2017-2022) & (KL)
Table 32. Global Biopharma Buffer Sales Market Share by Country/Region (2017-2022)
Table 33. Global Biopharma Buffer Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Biopharma Buffer Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Biopharma Buffer Sales by Country (2017-2022) & (KL)
Table 36. Americas Biopharma Buffer Sales Market Share by Country (2017-2022)
Table 37. Americas Biopharma Buffer Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Biopharma Buffer Revenue Market Share by Country (2017-2022)
Table 39. Americas Biopharma Buffer Sales by Type (2017-2022) & (KL)
Table 40. Americas Biopharma Buffer Sales Market Share by Type (2017-2022)
Table 41. Americas Biopharma Buffer Sales by Application (2017-2022) & (KL)
Table 42. Americas Biopharma Buffer Sales Market Share by Application (2017-2022)
Table 43. APAC Biopharma Buffer Sales by Region (2017-2022) & (KL)
Table 44. APAC Biopharma Buffer Sales Market Share by Region (2017-2022)
Table 45. APAC Biopharma Buffer Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Biopharma Buffer Revenue Market Share by Region (2017-2022)
Table 47. APAC Biopharma Buffer Sales by Type (2017-2022) & (KL)
Table 48. APAC Biopharma Buffer Sales Market Share by Type (2017-2022)
Table 49. APAC Biopharma Buffer Sales by Application (2017-2022) & (KL)
Table 50. APAC Biopharma Buffer Sales Market Share by Application (2017-2022)
Table 51. Europe Biopharma Buffer Sales by Country (2017-2022) & (KL)
Table 52. Europe Biopharma Buffer Sales Market Share by Country (2017-2022)
Table 53. Europe Biopharma Buffer Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Biopharma Buffer Revenue Market Share by Country (2017-2022)
Table 55. Europe Biopharma Buffer Sales by Type (2017-2022) & (KL)
Table 56. Europe Biopharma Buffer Sales Market Share by Type (2017-2022)
Table 57. Europe Biopharma Buffer Sales by Application (2017-2022) & (KL)
Table 58. Europe Biopharma Buffer Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Biopharma Buffer Sales by Country (2017-2022) & (KL)
Table 60. Middle East & Africa Biopharma Buffer Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Biopharma Buffer Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Biopharma Buffer Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Biopharma Buffer Sales by Type (2017-2022) & (KL)
Table 64. Middle East & Africa Biopharma Buffer Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Biopharma Buffer Sales by Application (2017-2022) & (KL)
Table 66. Middle East & Africa Biopharma Buffer Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Biopharma Buffer
Table 68. Key Market Challenges & Risks of Biopharma Buffer
Table 69. Key Industry Trends of Biopharma Buffer
Table 70. Biopharma Buffer Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Biopharma Buffer Distributors List
Table 73. Biopharma Buffer Customer List
Table 74. Global Biopharma Buffer Sales Forecast by Region (2023-2028) & (KL)
Table 75. Global Biopharma Buffer Sales Market Forecast by Region
Table 76. Global Biopharma Buffer Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Biopharma Buffer Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Biopharma Buffer Sales Forecast by Country (2023-2028) & (KL)
Table 79. Americas Biopharma Buffer Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Biopharma Buffer Sales Forecast by Region (2023-2028) & (KL)
Table 81. APAC Biopharma Buffer Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Biopharma Buffer Sales Forecast by Country (2023-2028) & (KL)
Table 83. Europe Biopharma Buffer Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Biopharma Buffer Sales Forecast by Country (2023-2028) & (KL)
Table 85. Middle East & Africa Biopharma Buffer Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Biopharma Buffer Sales Forecast by Type (2023-2028) & (KL)
Table 87. Global Biopharma Buffer Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Biopharma Buffer Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Biopharma Buffer Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Biopharma Buffer Sales Forecast by Application (2023-2028) & (KL)
Table 91. Global Biopharma Buffer Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Biopharma Buffer Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Biopharma Buffer Revenue Market Share Forecast by Application (2023-2028)
Table 94. Avantor Basic Information, Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 95. Avantor Biopharma Buffer Product Offered
Table 96. Avantor Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)
Table 97. Avantor Main Business
Table 98. Avantor Latest Developments
Table 99. Alfa Aesar (Thermo Fisher) Basic Information, Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 100. Alfa Aesar (Thermo Fisher) Biopharma Buffer Product Offered
Table 101. Alfa Aesar (Thermo Fisher) Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)
Table 102. Alfa Aesar (Thermo Fisher) Main Business
Table 103. Alfa Aesar (Thermo Fisher) Latest Developments
Table 104. Merck Basic Information, Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 105. Merck Biopharma Buffer Product Offered
Table 106. Merck Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)
Table 107. Merck Main Business
Table 108. Merck Latest Developments
Table 109. Lonza Basic Information, Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 110. Lonza Biopharma Buffer Product Offered
Table 111. Lonza Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)
Table 112. Lonza Main Business
Table 113. Lonza Latest Developments
Table 114. Bio-Rad Basic Information, Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 115. Bio-Rad Biopharma Buffer Product Offered
Table 116. Bio-Rad Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)
Table 117. Bio-Rad Main Business
Table 118. Bio-Rad Latest Developments
Table 119. BD Basic Information, Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 120. BD Biopharma Buffer Product Offered
Table 121. BD Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)
Table 122. BD Main Business
Table 123. BD Latest Developments
Table 124. GE Healthcare Basic Information, Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 125. GE Healthcare Biopharma Buffer Product Offered
Table 126. GE Healthcare Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)
Table 127. GE Healthcare Main Business
Table 128. GE Healthcare Latest Developments
Table 129. Promega Corporation Basic Information, Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 130. Promega Corporation Biopharma Buffer Product Offered
Table 131. Promega Corporation Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)
Table 132. Promega Corporation Main Business
Table 133. Promega Corporation Latest Developments
Table 134. Hamilton Company Basic Information, Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 135. Hamilton Company Biopharma Buffer Product Offered
Table 136. Hamilton Company Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)
Table 137. Hamilton Company Main Business
Table 138. Hamilton Company Latest Developments
Table 139. XZL BIO-TECHNOLOGY Basic Information, Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 140. XZL BIO-TECHNOLOGY Biopharma Buffer Product Offered
Table 141. XZL BIO-TECHNOLOGY Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)
Table 142. XZL BIO-TECHNOLOGY Main Business
Table 143. XZL BIO-TECHNOLOGY Latest Developments
Table 144. SRL Basic Information, Biopharma Buffer Manufacturing Base, Sales Area and Its Competitors
Table 145. SRL Biopharma Buffer Product Offered
Table 146. SRL Biopharma Buffer Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)
Table 147. SRL Main Business
Table 148. SRL Latest Developments
List of Figures
Figure 1. Picture of Biopharma Buffer
Figure 2. Biopharma Buffer Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biopharma Buffer Sales Growth Rate 2017-2028 (KL)
Figure 7. Global Biopharma Buffer Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Biopharma Buffer Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Phosphates Type
Figure 10. Product Picture of Acetates Type
Figure 11. Product Picture of TRIS Type
Figure 12. Product Picture of Others
Figure 13. Global Biopharma Buffer Sales Market Share by Type in 2021
Figure 14. Global Biopharma Buffer Revenue Market Share by Type (2017-2022)
Figure 15. Biopharma Buffer Consumed in Research Institution
Figure 16. Global Biopharma Buffer Market: Research Institution (2017-2022) & (KL)
Figure 17. Biopharma Buffer Consumed in Pharmaceutical Industry
Figure 18. Global Biopharma Buffer Market: Pharmaceutical Industry (2017-2022) & (KL)
Figure 19. Biopharma Buffer Consumed in Others
Figure 20. Global Biopharma Buffer Market: Others (2017-2022) & (KL)
Figure 21. Global Biopharma Buffer Sales Market Share by Application (2017-2022)
Figure 22. Global Biopharma Buffer Revenue Market Share by Application in 2021
Figure 23. Biopharma Buffer Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Biopharma Buffer Revenue Market Share by Company in 2021
Figure 25. Global Biopharma Buffer Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Biopharma Buffer Revenue Market Share by Geographic Region in 2021
Figure 27. Global Biopharma Buffer Sales Market Share by Region (2017-2022)
Figure 28. Global Biopharma Buffer Revenue Market Share by Country/Region in 2021
Figure 29. Americas Biopharma Buffer Sales 2017-2022 (KL)
Figure 30. Americas Biopharma Buffer Revenue 2017-2022 ($ Millions)
Figure 31. APAC Biopharma Buffer Sales 2017-2022 (KL)
Figure 32. APAC Biopharma Buffer Revenue 2017-2022 ($ Millions)
Figure 33. Europe Biopharma Buffer Sales 2017-2022 (KL)
Figure 34. Europe Biopharma Buffer Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Biopharma Buffer Sales 2017-2022 (KL)
Figure 36. Middle East & Africa Biopharma Buffer Revenue 2017-2022 ($ Millions)
Figure 37. Americas Biopharma Buffer Sales Market Share by Country in 2021
Figure 38. Americas Biopharma Buffer Revenue Market Share by Country in 2021
Figure 39. United States Biopharma Buffer Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Biopharma Buffer Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Biopharma Buffer Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Biopharma Buffer Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Biopharma Buffer Sales Market Share by Region in 2021
Figure 44. APAC Biopharma Buffer Revenue Market Share by Regions in 2021
Figure 45. China Biopharma Buffer Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Biopharma Buffer Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Biopharma Buffer Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Biopharma Buffer Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Biopharma Buffer Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Biopharma Buffer Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Biopharma Buffer Sales Market Share by Country in 2021
Figure 52. Europe Biopharma Buffer Revenue Market Share by Country in 2021
Figure 53. Germany Biopharma Buffer Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Biopharma Buffer Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Biopharma Buffer Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Biopharma Buffer Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Biopharma Buffer Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Biopharma Buffer Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Biopharma Buffer Revenue Market Share by Country in 2021
Figure 60. Egypt Biopharma Buffer Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Biopharma Buffer Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Biopharma Buffer Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Biopharma Buffer Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Biopharma Buffer Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Biopharma Buffer in 2021
Figure 66. Manufacturing Process Analysis of Biopharma Buffer
Figure 67. Industry Chain Structure of Biopharma Buffer
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...